CE Mark Approval on Device that Protects Critically Ill Patients from Pulmonary Embolism
Published date : 14 December 2012
Article date : 14 December 2012
Pharmabiz.com (India) reports that medical device manufacturer BiO2 Medical has received CE Mark approval for its triple lumen Angel Catheter. The device is described as a nitinol inferior vena cava filter, permanently attached to a central venous catheter, for the use of preventing pulmonary embolism in critically ill patients.
Apparently, the catheter provides instant protection from PE and is the first IVC Filter to receive CE Mark approval for prophylactic indications.
Source: Pharmabiz.com, 11 December 2012